Ipca Laboratories Ltd (BOM:524494)
₹ 1556.65 -0.9 (-0.06%) Market Cap: 394.93 Bil Enterprise Value: 400.86 Bil PE Ratio: 68.48 PB Ratio: 6.24 GF Score: 91/100

Q2 2024 IPCA Laboratories Ltd Earnings Call Transcript

Nov 10, 2023 / 10:30AM GMT
Release Date Price: ₹1050.8 (+0.38%)
Operator

Ladies and gentlemen, good day, and welcome to Ipca Laboratories Q2 FY '24 Earnings Conference Call, hosted by DAM Capital Advisors. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Nitin Agarwal from DAM Capital Advisors. Thank you, and over to you, sir.

Nitin Agarwal
DAM Capital Advisors Limited, Research Division - Head of Research

Thank you. Good afternoon, everyone, and a very warm welcome to Ipca Labs Q2 FY '24 post results earnings call hosted by DAM Capital Advisors. I -- on the call today are representing the Ipca management, Mr. A.K. Jain, Joint Managing Director; and Mr. Harish Kamath, Company Secretary. I'll hand over the call to the management team to make the opening comments, and then we'll open the floor for questions. Please go ahead, sir.

Ajit Kumar Bhanwarlal Jain
Ipca Laboratories Limited - CFO, MD & Executive Director

Thanks, Nitin, and DAM Capital Advisors for organizing this call. Good afternoon, and happy Dhanteras to all

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot